PMC4179434_01
Response to pazopanib therapy in case 1. a. PET-CT at baseline and after 3 months of pazopanib treatment. b. Chest radiograph at baseline and after 4.5 months of pazopanib treatment.
2045-3329-4-13-1.jpg
PMC4179434_01_2045-3329-4-13-1.jpg
F1
SUV for pelvic wall mass from 5.2 to 1.5 and right upper lung mass from 5.9 to 2.0) (Figure  1). She is now on her 5th month of pazopanib therapy, and continues to maintain a 'partial response'.
PMC4179434_02
PMC4179434_03